Detalles de la búsqueda
1.
Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology study.
Gynecol Oncol
; 161(2): 512-515, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33610319
2.
Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol
; 158(3): 562-569, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32641240
3.
A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer.
Gynecol Oncol
; 156(1): 13-22, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31708167
4.
Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study.
Gynecol Oncol
; 155(3): 420-428, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31623857
5.
A Phase I Evaluation of Extended Field Radiation Therapy With Concomitant Cisplatin Chemotherapy Followed by Paclitaxel and Carboplatin Chemotherapy in Women With Cervical Carcinoma Metastatic to the Para-aortic Lymph Nodes: An NRG Oncology/Gynecologic Oncology Group Study.
Gynecol Oncol
; 151(2): 202-207, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30174176
6.
A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 147(2): 283-290, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28802766
7.
A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 145(2): 236-242, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28341300
8.
A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 140(2): 204-9, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26616225
9.
A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): an NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 138(1): 36-40, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25958319
10.
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer.
Breast Cancer Res Treat
; 137(2): 483-92, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23242585
11.
A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors.
Am J Clin Oncol
; 46(8): 353-359, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37264515
12.
Durable control of metastases in an HLA-A2+ patient with refractory melanoma after low-dose radiotherapy in combination with MAGE-A4 T cell therapy: a case report.
Melanoma Res
; 33(4): 332-337, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37325860
13.
Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial.
Nat Med
; 29(1): 104-114, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36624315
14.
A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
Gynecol Oncol
; 125(1): 54-8, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22155262
15.
A phase I study of concurrent weekly topotecan and cisplatin chemotherapy with whole pelvic radiation therapy in locally advanced cervical cancer: a gynecologic oncology group study.
Gynecol Oncol
; 125(1): 158-62, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22198338
16.
A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
Gynecol Oncol
; 127(3): 506-10, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22943879
17.
A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group study.
Gynecol Oncol
; 127(3): 456-61, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22960004
18.
A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies.
Am J Clin Oncol
; 45(7): 294-297, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35700081
19.
An Exploratory Study of Neoadjuvant Cetuximab Followed by Cetuximab and Chemoradiotherapy in Women With Newly Diagnosed Locally Advanced Cervical Cancer.
Am J Clin Oncol
; 45(7): 286-293, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35696702
20.
Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors.
Front Oncol
; 12: 818679, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35372008